secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESAB Corp (ESAB)
CIK:        0001877322
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001877322-22-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ESAB Q3 beats: core adj. EPS $0.92, raises FY core adj. EPS guidance to $4.00-$4.10
--------------------------------------------------------------------------------

- GAAP EPS $0.88, core adjusted diluted EPS $0.92; net income $53M from continuing ops.
- Revenue $620M (+2% reported); core organic growth 10% excluding Russia and currency.
- Core adjusted EBITDA $96M, up 5% YoY; reaffirms 2022 core organic growth 11-14%.
- Raises FY core adjusted EPS guidance to $4.00-$4.10 from $3.85-$4.05; core EBITDA narrowed to $405-415M.
- Completed Ohio Medical acquisition; gas control platform now >$400M sales with >40% gross margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877322/000187732222000019/0001877322-22-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877322/000187732222000019/esab-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001877322-22-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer